Episode 398: How Breakthrough Discoveries in MS Research Will Impact MS Care with Dr. Amit Bar-Or

Last week, at the American Academy of Neurology annual meeting, Dr. Amit Bar-Or received the John Dystel Prize for Multiple Sclerosis Research for his multiple achievements that have advanced our knowledge of neuroimmunology, precision medicine, and biomarkers in MS. We talked with Dr. Bar-Or about how some of the latest discoveries in MS research would impact patient care.

 

Tolebrutinib, an investigational disease-modifying therapy, is currently making its way through the FDA's regulatory process. Last week, the results of the Phase 3 clinical trials for Tolebrutinib were published, and we're sharing the details.

We'll also tell you about MindGlide, an AI-powered tool for analyzing MRI scans that will significantly reduce MRI exam times.

We're talking about the results of the Phase 3 clinical trial for high-dose Ocrevus.

And we'll tell you about a cell therapy that doesn't use stem cells that successfully repaired myelin in the mouse model of MS -- twice! 

We have a lot to talk about! Are you ready for RealTalk MS??!

---

Congratulations to Dr. Stephen Hauser and Dr. Alberto Ascherio  :22

This Week: The impact of breakthrough MS research on MS care  2:17

Results of the phase 3 clinical trials for Tolebrutinib have been published  3:07

An AI-powered tool for analyzing MRI scans will significantly reduce MRI exam times for patients  4:21

Results of the phase 3 clinical trial for high-dose Ocrevus  8:13

A cell therapy that doesn't use stem cells has successfully repaired myelin in the mouse model of MS -- twice!  10:14

Dystel Prize winner Dr. Amit Bar-Or discusses how some of the latest discoveries in MS  research will impact MS care  12:39

Share this episode  22:36

Have you downloaded the free RealTalk MS app?  22:56

---

SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email: https://realtalkms.com/397

ADD YOUR VOICE TO THE CONVERSATION

I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!

Email: [e-mail]
Phone: [phone]

And don't forget to join us in the RealTalk MS Facebook group!

---

LINKS

If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the .css-j9qmi7{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-direction:row;-ms-flex-direction:row;flex-direction:row;font-weight:700;margin-bottom:1rem;margin-top:2.8rem;width:100%;-webkit-box-pack:start;-ms-flex-pack:start;-webkit-justify-content:start;justify-content:start;padding-left:5rem;}@media only screen and (max-width: 599px){.css-j9qmi7{padding-left:0;-webkit-box-pack:center;-ms-flex-pack:center;-webkit-justify-content:center;justify-content:center;}}.css-j9qmi7 svg{fill:#27292D;}.css-j9qmi7 .eagfbvw0{-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;color:#27292D;}